Expand INDV Menu
INDV MENU

INDV Latest Press Releases

-- March 17, 2026 --

National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder Globe Newswire 12:01 PM

-- March 12, 2026 --

Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering Globe Newswire 8:30 PM
Indivior Announces Proposed Convertible Senior Notes Offering Globe Newswire 7:00 AM

-- March 11, 2026 --

New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder Globe Newswire 9:00 AM

-- February 26, 2026 --

Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results Globe Newswire 7:00 AM

-- February 24, 2026 --

Indivior to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- January 28, 2026 --

Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26?? Globe Newswire 7:00 AM

-- January 26, 2026 --

Indivior Announces Completion of Redomiciliation to the United States Globe Newswire 7:00 AM

-- January 8, 2026 --

Indivior Provides Full-Year 2026 Financial Guidance and Business Update Globe Newswire 7:00 AM

-- December 22, 2025 --

Indivior Announces Inclusion in the S&P SmallCap 600 Index PRNewswire 7:00 AM

-- December 17, 2025 --

New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations PRNewswire 11:30 AM

-- December 5, 2025 --

CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PRNewswire 5:50 PM

-- November 20, 2025 --

Indivior Concludes Legacy U.S. Department of Justice Matter PRNewswire 4:01 PM

-- November 19, 2025 --

Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference PRNewswire 9:21 AM

-- November 3, 2025 --

Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine PRNewswire 8:00 AM

-- October 30, 2025 --

Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance PRNewswire 7:01 AM

-- October 28, 2025 --

Indivior to Participate in the Stifel 2025 Healthcare Conference PRNewswire 10:00 AM
Market Data Delayed 15 Minutes